Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,891.00
Bid: 1,887.00
Ask: 1,889.00
Change: 16.00 (0.85%)
Spread: 2.00 (0.106%)
Open: 1,897.00
High: 1,897.00
Low: 1,877.00
Prev. Close: 1,875.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday tips round-up: Hikma, African Barrick, Lenovo

Fri, 17th Aug 2012 06:58

What a difference a year makes, Tempus in The Times proclaims. When the Arab Spring was in full flow, investors worried that Hikma Pharmaceuticals was too exposed to the unstable region. The company, based in Jordan, almost halved last year's sales growth forecast as governments fell. Now it looks well placed to benefit from the region's recovery ? and investors are grateful that it has largely escaped the eurozone crisis, which has seen governments slash healthcare spending. The company is gradually shifting production to the developing world, where costs are cheaper. Analysts say that Hikma has better growth prospects than its European rivals, a view confirmed by yesterday's results. Shares rose five per cent yesterday, but are still off the high reached before the Arab Spring unfolded. Now an Arab Spring premium should apply. Buy, says Tempus.Hold African Barrick Gold (ABG) until the bid situation becomes clear is the advice of Questor in the Daily Telegraph. Two state-owned companies have approached African Barrick Gold's (ABG) parent company Barrick Gold with a view to making an offer for part, or whole, of ABG. Barrick Gold is continuing talks with China National Gold, after it apparently rejected a low-ball bid from Zijin Mining Group. Questor thinks Barrick Gold is more likely to sell a portion of its stake rather than sell out completely. This latest move by China may or may not mark the start of a wave of mergers in gold miners. However, the sector certainly looks ripe for consolidation for companies with the financial muscle to buy quality assets. Questor last said ABG shares were a speculative buy on July 24th when they stood at 317p. They are now 34% above that level and because the bid situation is unclear, the rating is now cut to hold.Chinese companies know all about "zouchuqu" - going out and staking a claim in global markets whatever the cost, observes Lex, as the Financial Times's venerable column takes a look at the world's second largest PC maker, Lenovo. On Thursday, the PC maker said that in the past three months it increased revenues 35% from a year earlier, and widened its paper-thin margins enough to increase operating profit by nearly 50%. Good work, but there is more to be done. While Lenovo's share in the PC market is now just short of global leader Hewlett-Packard's, its operating margins are a quarter of HP's. Progress may take time, though. This month it announced a partnership with EMC, the US storage server group that once worked with Dell. Margins are fatter in the server market, but Lenovo will be up against tough competitors in HP, IBM and Dell, who control three-quarters of it. However, any Chinese company that has proved it can combine global ambition and improving profitability deserves the benefit of the doubt.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.JH
More News
4 Sep 2020 10:50

Barclays upgrades Hikma after US court ruling

(Sharecast News) - Barclays upgraded Hikma Pharmaceuticals to 'overweight' and increased its price target on the company's shares after a US court ruled in favour of the generic drugmaker's treatment for heart conditions.

Read more
4 Sep 2020 09:36

UK BROKER RATINGS SUMMARY: Upgrades For Hikma And Imperial Brands

UK BROKER RATINGS SUMMARY: Upgrades For Hikma And Imperial Brands

Read more
4 Sep 2020 07:54

LONDON BRIEFING: Ryanair Raises Funds, Eyeing Post-Virus Opportunities

LONDON BRIEFING: Ryanair Raises Funds, Eyeing Post-Virus Opportunities

Read more
3 Sep 2020 18:38

US court of appeals upholds ruling in favour of Hikma over Vascepa

(Sharecast News) - US courts ruled against an appeal by Amarin related to Hikma Pharmaceuticals's generic treatment for heart conditions, Vascepa.

Read more
3 Sep 2020 17:49

Hikma Receives Favourable Court Ruling For Its Generic Vascepa

Hikma Receives Favourable Court Ruling For Its Generic Vascepa

Read more
17 Aug 2020 10:27

Ex-divs to take 7.7 points off FTSE 100 on 20 August

By Joice Alves LONDON, Aug 17 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current ma...

Read more
13 Aug 2020 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
7 Aug 2020 17:05

LONDON MARKET CLOSE: FTSE Edges Up After Better-Than-Forecast US Jobs

LONDON MARKET CLOSE: FTSE Edges Up After Better-Than-Forecast US Jobs

Read more
7 Aug 2020 12:19

LONDON MARKET MIDDAY: Stocks Mixed As Sunak Resists Furlough Extension

LONDON MARKET MIDDAY: Stocks Mixed As Sunak Resists Furlough Extension

Read more
7 Aug 2020 11:45

UPDATE 2-UK's Hikma making Gilead's COVID-19 drug remdesivir to increase supply

* Gilead deal and strong profits push Hikma shares up 10%* Remdesivir seen as one of most promising COVID-19 treatments* Gilead contracting out manufacturing to ensure supplies (Updating with details throughout)By Pushkala AripakaAug 7 (Reuters) - ...

Read more
7 Aug 2020 10:45

UK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance

UK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance

Read more
7 Aug 2020 09:33

UPDATE 2-London stocks gain on week; U.S. jobs data, tensions with China weigh

(For a live blog on European stocks, type LIVE/ in an Eikon news window)* U.S. employment rise beats expectations but falls sharply m-o-m* AstraZeneca rises 0.6%; Japan strikes deal for COVID-19 vaccine* UK confident of Brexit trade deal as EU cha...

Read more
7 Aug 2020 09:33

UPDATE 2-European stocks end week with gains on telecoms, tech boost

(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Tech investor Prosus hit by U.S. move on Chinese apps* Deutsche Telekom boosted by T-Mobile's upbeat Q2 report* Main regional indexes record weekly gains (Updates with market...

Read more
7 Aug 2020 08:56

LONDON MARKET OPEN: Hikma And Hargreaves Lansdown Lead FTSE 100 Higher

LONDON MARKET OPEN: Hikma And Hargreaves Lansdown Lead FTSE 100 Higher

Read more
7 Aug 2020 08:40

LIVE MARKETS-Opening snapshot: Waiting for U.S. data

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) i...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.